Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.
Choose from the criteria below to find an activity that fits you best.
|A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC)|
The regulatory landscape of antimicrobial stewardship has changed greatly since
2012 as part of coordinated national and international efforts to combat antimicrobial
resistance. This offering will provide an update of the current regulatory requirements
regarding stewardship and describe initiatives and proposed rules on the horizon from
government agencies and other organizations. This will include a discussion of stewardship
in the acute care, ambulatory and long-term care settings. Other areas of opportunity
for stewardship programs including formats for benchmarking antibiotic use through
the National Healthcare Safety Network (NHSN) Antimicrobial use and resistance (AUR)
module and available incentives to report will also be reviewed.
This is a featured CE activity on the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) website. SIDPEC is the educational hub of the Society of Infectious Diseases Pharmacists (SIDP). The SIDPEC portal provides educational activities on infectious disease pharmacotherapy for clinical pharmacists, health‐systems pharmacists, community pharmacists, and other allied‐health disciplines.
At the conclusion of this activity, participants should be able to:
Elizabeth Dodds-Ashley, PharmD, MHS, FCCP, BCPS
Associate Professor of Medicine
Co-Director of Operations, Duke Antimicrobial Stewardship Outreach Network
Department of Medicine, Division of Infectious Diseases and International Health
Durham, North Carolina
No commercial funding was received for this activity.
Release Date: 7-21-2017
Expiration Date: 7-21-2020
This CE activity is jointly provided by ProCE, Inc. and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-136-H04-P has been assigned to this knowledge-based home-study CE activity (initial release date 7-21-2017). This CE activity is approved for 0.75 contact hour (0.075 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and
scientific rigor in all of its continuing education activities. Faculty must disclose
to participants any significant financial interest or affiliation with companies that
manufacture or market products discussed in this activity. Dr. Dodds-Ashley has
served as a Speaker and/or Consultant for the Greater New York Hospital Association
(GNYHA), the Healthcare Association of New York State (HANYS), the New York State
Council of Health-system Pharmacists (NYSCHP), and the Society for Healthcare Epidemiology
of America (SHEA).
Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.